RU2019125378A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2019125378A3 RU2019125378A3 RU2019125378A RU2019125378A RU2019125378A3 RU 2019125378 A3 RU2019125378 A3 RU 2019125378A3 RU 2019125378 A RU2019125378 A RU 2019125378A RU 2019125378 A RU2019125378 A RU 2019125378A RU 2019125378 A3 RU2019125378 A3 RU 2019125378A3
- Authority
- RU
- Russia
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17156518.7 | 2017-02-16 | ||
| EP17156518.7A EP3363802B1 (en) | 2017-02-16 | 2017-02-16 | Crystalline form of cabotegravir sodium |
| EP17161414.2 | 2017-03-16 | ||
| EP17161414 | 2017-03-16 | ||
| PCT/EP2018/051819 WO2018149608A1 (en) | 2017-02-16 | 2018-01-25 | Crystalline forms of cabotegravir sodium |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2019125378A3 true RU2019125378A3 (ru) | 2021-03-16 |
| RU2019125378A RU2019125378A (ru) | 2021-03-16 |
Family
ID=61168064
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2019125378A RU2019125378A (ru) | 2017-02-16 | 2018-01-25 | Кристаллические формы каботегравира натрия |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US11040986B2 (ru) |
| EP (1) | EP3583107B1 (ru) |
| CN (1) | CN110582504A (ru) |
| AU (2) | AU2018221379B2 (ru) |
| CA (1) | CA3053202C (ru) |
| MX (2) | MX388699B (ru) |
| RU (1) | RU2019125378A (ru) |
| WO (1) | WO2018149608A1 (ru) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110582504A (zh) * | 2017-02-16 | 2019-12-17 | 桑多斯股份公司 | 卡博特韦钠的晶形 |
| WO2023175386A2 (en) * | 2021-10-08 | 2023-09-21 | Laurus Labs Limited | Processes for preparation of cabotegravir or its pharmaceutically acceptable salts thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20160757T1 (hr) | 2004-04-19 | 2016-08-12 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Postupak za proizvodnju polimorfnog oblika i od klopidogrel-vodik-sulfata |
| CN101212903B (zh) * | 2005-04-28 | 2013-07-24 | 史密丝克莱恩比彻姆公司 | 具有hiv整合酶抑制活性的多环氨基甲酰基吡啶酮衍生物 |
| JP4295353B2 (ja) | 2005-04-28 | 2009-07-15 | スミスクライン ビーチャム コーポレーション | Ｈｉｖインテグラーゼ阻害活性を有する多環性カルバモイルピリドン誘導体 |
| EP3210603A1 (en) | 2008-12-11 | 2017-08-30 | Shionogi & Co., Ltd | Synthesis of carbamoylpyridone hiv integrase inhibitors and intermediates |
| TWI582097B (zh) | 2010-03-23 | 2017-05-11 | Ｖｉｉｖ醫療保健公司 | 製備胺甲醯吡啶酮衍生物及中間體之方法 |
| WO2015139591A1 (zh) | 2014-03-19 | 2015-09-24 | 杭州普晒医药科技有限公司 | 德罗格韦钠盐的晶型及其制备方法 |
| ZA201503540B (en) | 2014-05-20 | 2016-10-26 | Cipla Ltd | Process for preparing polycyclic carbamoyl pyridone derivatives |
| WO2018109786A1 (en) * | 2016-12-16 | 2018-06-21 | Cipla Limited | Novel polymoprphs and salts of polycyclic carbamoyl pyridone derivatives |
| CN110582504A (zh) * | 2017-02-16 | 2019-12-17 | 桑多斯股份公司 | 卡博特韦钠的晶形 |
-
2018
- 2018-01-25 CN CN201880025341.0A patent/CN110582504A/zh active Pending
- 2018-01-25 MX MX2019009810A patent/MX388699B/es unknown
- 2018-01-25 US US16/485,541 patent/US11040986B2/en active Active
- 2018-01-25 EP EP18703516.7A patent/EP3583107B1/en active Active
- 2018-01-25 RU RU2019125378A patent/RU2019125378A/ru unknown
- 2018-01-25 WO PCT/EP2018/051819 patent/WO2018149608A1/en not_active Ceased
- 2018-01-25 CA CA3053202A patent/CA3053202C/en active Active
- 2018-01-25 AU AU2018221379A patent/AU2018221379B2/en active Active
-
2019
- 2019-08-15 MX MX2021015441A patent/MX2021015441A/es unknown
-
2021
- 2021-05-19 US US17/324,661 patent/US20210300945A1/en active Granted
-
2022
- 2022-01-27 AU AU2022200513A patent/AU2022200513B2/en active Active
-
2025
- 2025-02-25 US US19/062,328 patent/US20250236630A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3053202C (en) | 2022-10-04 |
| US20200385401A1 (en) | 2020-12-10 |
| MX2019009810A (es) | 2019-12-02 |
| RU2019125378A (ru) | 2021-03-16 |
| AU2018221379A1 (en) | 2019-08-29 |
| US20210300945A1 (en) | 2021-09-30 |
| CA3053202A1 (en) | 2018-08-23 |
| AU2018221379B2 (en) | 2021-11-04 |
| EP3583107B1 (en) | 2020-11-18 |
| US11040986B2 (en) | 2021-06-22 |
| US20250236630A1 (en) | 2025-07-24 |
| AU2022200513A1 (en) | 2022-02-17 |
| EP3583107A1 (en) | 2019-12-25 |
| MX388699B (es) | 2025-03-20 |
| WO2018149608A1 (en) | 2018-08-23 |
| MX2021015441A (es) | 2022-01-24 |
| AU2022200513B2 (en) | 2023-11-02 |
| CN110582504A (zh) | 2019-12-17 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HZ9A | Changing address for correspondence with an applicant |